Navigation Links
Nominations Open for the Inaugural Harrington Prize for Innovation in Medicine
Date:4/30/2013

CLEVELAND, April 30, 2013 /PRNewswire/ -- National and international nominations are being sought for the inaugural Harrington Prize for Innovation in Medicine, which will honor a medical researcher for notable achievements in innovation, creativity, and potential for clinical application.

The Harrington Prize, which carries a $20,000 honorarium, is the result of collaboration between the American Society for Clinical Investigation (ASCI), one of the nation's oldest and most respected medical honor societies, and the Harrington Discovery Institute at University Hospitals Case Medical Center. The Harrington Discovery Institute is a national initiative dedicated to physician-scientists, enabling them to transform breakthrough insights into novel therapies that enhance patient care. Both organizations understand the scientific and administrative hurdles that hinder advancement of discovery into medicines that improve human health, and they are eager to highlight those who have navigated the path successfully.

Deadline for nominations is June 28, 2013.
A nomination form can be found at: HarringtonDiscovery.org/ThePrize

A committee composed of members of the ASCI Council and the Harrington Discovery Institute Scientific Advisory Board will review nominations and select the recipient. In addition to the honorarium, the awardee delivers the Harrington Prize Lecture at the 2014 ASCI/AAP Joint Meeting (April 25-27) and publishes a review in the Journal of Clinical Investigation.

For more information about Harrington Prize nominations, ASCI, and the Harrington Discovery Institute, please visit HarringtonDiscovery.org or contact Natalie Haynes , Harrington Discovery Institute Program Manager, at 216-368-1038 or Natalie.Haynes@UHhospitals.org

About the ASCI

The American Society for Clinical Investigation (ASCI), established in 1908, is one of the nation's oldest and most respected medical honor societies. The ASCI comprises more than 3,000 physician-scientists from all medical specialties elected to the Society for their outstanding records of scholarly achievement in biomedical research. The ASCI represents active physician-scientists who are at the bedside, at the research bench, and at the blackboard. Many of its members are widely recognized leaders in academic medicine. The ASCI is dedicated to the advancement of research that extends our understanding and improves the treatment of human diseases, and members are committed to mentoring future generations of physician-scientists. The ASCI considers the nominations of several hundred physician-scientists from the United States and abroad each year and elects up to 80 new members each year for their significant research accomplishments.

About University Hospitals

University Hospitals serves the needs of patients through an integrated network of hospitals, outpatient centers and primary care physicians. At the core of our health system is University Hospitals Case Medical Center. The primary affiliate of Case Western Reserve University School of Medicine, UH Case Medical Center is home to some of the most prestigious clinical and clinical research centers of excellence in the nation and the world, including cancer, pediatrics, women's health, orthopaedics and spine, radiology and radiation oncology, neurosurgery and neuroscience, cardiology and cardiovascular surgery, organ transplantation and human genetics. Its main campus includes the internationally celebrated UH Rainbow Babies & Children's Hospital, ranked among the top children's hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. For more information, go to UHhospitals.org.


'/>"/>
SOURCE University Hospitals Case Medical Center
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. BRAVE Awards Now Accepting Nominations
2. Genuine Bio-Fuel Inc. Notes Sustainable Energy Gets A Much Needed Boost from the President Obama During 2013 Inaugural Address
3. Bayer CropScience Hosts Inaugural Vegetable Future Forum in Monheim
4. USC Center For Applied Molecular Medicine To Honor Sumner Redstone And Murray Gell-Mann, Ph.D. At The Inaugural REBELS WITH A CAUSE Gala
5. BioLife Solutions Announces Presentation at IBC Inaugural Cell Therapy Clinical Development Conference
6. Tufts Medical Center Announces Inaugural INNOVATION Day: Innovating a Path to Market
7. Maine Center for Creativity Selects Glenn Close and David Shaw to Receive Inaugural Maine Creative Industry Award
8. Inaugural Meeting of the FirstMark Scientific Board of Advisors
9. Douglas Harrington, MD Addresses Select Group Of Physicians Regarding Latest Advances In Cardiovascular Risk Assessment
10. Aviir, Inc.s CEO Dr. Douglas Harrington Delivered The Facts Surrounding Heart Disease At The Los Angeles Ultimate Womens Expo
11. 3D Biomatrix Technology Recognized by NC3Rs 3Rs Prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Feb. 17, 2017  If only one in ... a mutation-conferring resistance to chemotherapy, thousands of cancer ... has focused on finding these mutations in ever-smaller ... circulating tumor DNA in blood — to guide ... Unfortunately, however, detecting these genetic anomalies ...
(Date:2/16/2017)...  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company harnessing ... treatment for triple negative breast cancer (TNBC), announced today their ... program. The YEi Start in ... entrepreneurs grow their business in France ... selected to complete an intensive one week immersion in ...
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
Breaking Biology Technology:
(Date:2/3/2017)... A new independent identity strategy consultancy firm announces its ... to fill a critical niche in technical and policy ... Mark Crego and Janice Kephart together ... that span federal governments, the 9/11 Commission, private industry, ... has a common theme born from a shared passion ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
(Date:1/24/2017)... , Jan. 24, 2017 Biopharm ... of the laboratory use of nuclear magnetic resonance ... experienced end-users and profiled current practices, developments, trends ... as well as growth and opportunities. These areas ... suppliers, NMR instruments, needs and innovation requirements, hyphenated ...
Breaking Biology News(10 mins):